The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 07, 2025

Filed:

Jan. 15, 2025
Applicant:

Amsinomed Medical Co., Ltd, Beijing, CN;

Inventors:

Dongyun Hao, Beijing, CN;

Bo Yu, Beijing, CN;

Kefei Dou, Beijing, CN;

Xin Shen, Beijing, CN;

Bili Zhang, Beijing, CN;

Fugui He, Beijing, CN;

Lifeng Zhou, Beijing, CN;

Xiaoyi Ma, Beijing, CN;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 2/89 (2013.01); A61F 2/88 (2006.01); A61L 31/02 (2006.01); A61L 31/10 (2006.01); A61L 31/16 (2006.01);
U.S. Cl.
CPC ...
A61F 2/88 (2013.01); A61F 2/89 (2013.01); A61L 31/022 (2013.01); A61L 31/10 (2013.01); A61L 31/16 (2013.01); A61F 2210/0076 (2013.01); A61F 2220/0033 (2013.01); A61F 2240/001 (2013.01); A61F 2250/0067 (2013.01); A61L 2300/102 (2013.01); A61L 2300/216 (2013.01); A61L 2300/41 (2013.01); A61L 2300/416 (2013.01); A61L 2300/606 (2013.01); A61L 2420/02 (2013.01); A61L 2420/06 (2013.01);
Abstract

A cobalt-chromium alloy stent comprising several main body units, wherein each main body unit is composed of several supporting rings connected by flexible ribs and the adjacent main body units are connected by several connecting ribs. A drug eluting stent comprising the cobalt-chromium alloy stent and a drug coating containing arsenic trioxide and tacrolimus. The drug release curves of the two composite drugs of arsenic trioxide and tacrolimus used in the present invention are adjusted, so that the inflammatory response of vascular endothelial cells and the proliferation behavior of vascular smooth muscle cells are effectively inhibited, and the vascular restenosis rate is reduced.


Find Patent Forward Citations

Loading…